NEW YORK, Sept. 22 (GenomeWeb News) - Genome Canada will fund the Atlantic Medical Genetics and Genome Initiative, a Canadian disease genotyping project, with CA$3.2 million ($2.8 million), Genome Atlantic, a regional Genome Canada affiliate, said yesterday in a statement.
The initiative is a joint project that involves Memorial University and Dalhousie University, along with Genome Atlantic and The Atlantic Genome Center, the company said. The balance of the project's total funding of CA$9.2 ($7.9 million) will come from a "range of regional innovation and health research partners, Genome Atlantic said.
"Our research will pinpoint the genes that are the root causes of over 25 genetic diseases that affect Atlantic Canadians, and contribute to our overall understanding of the function of the 25,000 genes in the human genome," said Mark Samuels, a molecular researcher at Dalhousie University and co-principal investigator of AMGGI.
"This research will lead to improved methods for the early diagnosis of genetic diseases," including new genetic tests, said Pat Parfrey, clinical researcher at Memorial University and AMGGI investigator.